Critical Insights into Mpox Transmission in Central Africa You Can’t Ignore
Explore the complexities of Mpox Transmission in Central Africa, with insights into how the mutated virus spreads and its impact on vulnerable populations.
Stay informed with the latest updates and insights on pharmaceuticals at Med Pharma News. Explore breaking news, industry trends, research advancements, and regulatory developments shaping the pharmaceutical landscape.
Explore the complexities of Mpox Transmission in Central Africa, with insights into how the mutated virus spreads and its impact on vulnerable populations.
India’s preparedness against Mpox is robust, featuring heightened surveillance, strategic reviews, and health unit sensitization to effectively manage any potential outbreaks following WHO’s global health emergency declaration.
Ascendis Pharma hormone disorder therapy has been granted US FDA approval. Discover the groundbreaking treatment and its potential impact on patients with hormone disorders.
The first Mpox case outside Africa has been confirmed, raising concerns about the global spread of the virus. Learn about symptoms, transmission, and prevention strategies in our in-depth report.
Explore how the US Biosecure Act targets China’s pharmaceutical exports and is expected to double India’s pharma contract manufacturing within three years. Learn about the Act’s implications on global pharma trade and the strategic shift towards India’s manufacturing capabilities.
Perrigo recalls 16500 cans of infant formula due to potential health risks. Learn about the causes, safety concerns, and steps to take if you have purchased the recalled product.
The European Medicines Agency has rejected the Alzheimer’s drug from Eisai and Biogen due to safety concerns. Learn more about the implications for Alzheimer’s treatment.
GSK settles heartburn drug lawsuit in Illinois, addressing claims that Zantac caused cancer. This settlement marks a significant development in ongoing litigation and highlights the importance of drug safety.
In a landmark legal decision that has sent shockwaves through the pharmaceutical industry, court has ordered Abbott to pay $495 million in damages. The ruling,… Read More »Abbott to Pay $495 Million in Damages in a Shocking Court Ruling